Eli Lilly and Company holds the cleaner structural position, with the lead spread across profitability and stability. UCB still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. On the market side, Eli Lilly and Company is in better shape — its trend is intact while UCB's trend has broken down. That puts structure and market broadly in agreement — Eli Lilly and Company's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (LLY: S&P 500, UCB.BR: STOXX 600).
The comparison is mainly decided in profitability, with the rest of the profile carrying less weight. The overall score gap is 16 points in favour of Eli Lilly and Company.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
Most of the shared profile comes through margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Eli Lilly and Company is stronger, but the price setup still looks more supportive for UCB SA.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where LLY and UCB.BR each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 20.9-point operating margin advantage.
Stability still leans toward UCB SA, so the lead is real without reading as one-way.
The profitability lead is clear, but pricing and stability still pull in the other direction — the result holds, but not without friction.
Break down the LLY vs UCB.BR comparison across all dimensions with the full interactive tool.
Explore how LLY and UCB.BR each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.